| Authors: |
Eyre TA; Oxford Cancer and Haematology Centre, Churchill Hospital, Headington, Oxford, United Kingdom., Song Y; Peking University Cancer Hospital and Institute, Beijing, China., Hermine O; Necker Hospital Assistance Publique Hôpitaux de Paris, Paris Cité University, Imagine Institute, INSERM U 1163, Paris, France., Shuang Y; Jiangxi Province Hospital, Nanchang, China., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland., Farias JS; Hospital Erasto Gaertner, Curitiba, Brazil., Mahuad C; Hospital Alemán, Buenos Aires, Argentina., Özcan M; Ankara University School of Medicine, Ankara, Turkey., Jachimowicz RD; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, and Max Planck Institute for Biology of Ageing, Cologne, Germany., Chen T; BeOne Medicines, Ltd, San Carlos, CA., Ivanova E; BeOne Medicines, Ltd, Sydney, NSW, Australia., Li X; BeOne Medicines, Ltd, Shanghai, China., Man G; BeOne Medicines, Ltd, San Carlos, CA., Bourquelot P; BeOne Medicines, Ltd, San Carlos, CA., Vezan R; BeOne Medicines, Ltd, San Carlos, CA., Wang M; The University of Texas MD Anderson Cancer Center, Houston, TX. |
